Buscar
NOTICIAS

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Por un escritor de hombre misterioso

Medsafe has won praise for moving quickly to stop sales of a herbal remedy linked to Covid-19.

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19), BMC Complementary Medicine and Therapies

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

COVID-19 Lockdown Exit Analysis

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care - National Home Infusion Association

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Item 11470 - Avalo® Treatment Cart

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment - ScienceDirect

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Artemisia plant extracts show potential anti-SARS-CoV-2 activity in vitro

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

False advertising over Covid-19 cures targeted by Commerce Commission

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

A Pilot Study of Ocrelizumab Infusion Reaction Rates Among Multiple Sclerosis Patients Treated in a Hospital and 2 Outpatient Sites of Care - National Home Infusion Association

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Artemisia Annua Could Be Promising Treatment for COVID-19

Medsafe blocks sales of Covid-19 'treatment' Artemisia annua

Artemisia annua to be tested against COVID-19 Max Planck Institute of Colloids and Interfaces